APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Circulating Biomarker

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Circulating Biomarker Industry Growth and Trends Forecast to 2032

Report ID 173978280122 December 202593 pages

Choose your research edition.

Industry ResearchCirculating Biomarker Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Circulating Biomarker Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Circulating Biomarker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Circulating Biomarker Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Circulating Biomarker Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Circulating Biomarker market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Circulating Biomarker is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Circulating Biomarker is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Circulating Biomarker is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Circulating Biomarker include GE Healthcare, Fluxion Biosciences, Epigenomics AG, Biocept, Becton, Dickinson and Company, Agilent Technologies, Affymetrix and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Circulating Biomarker market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Circulating Biomarker market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Circulating Biomarker market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Circulating Biomarker.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Circulating Biomarker market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Circulating Biomarker Market by Company

GE Healthcare

Fluxion Biosciences

Epigenomics AG

Biocept

Becton, Dickinson and Company

Agilent Technologies

Affymetrix

Abbott Laboratories

Circulating Biomarker Segment by Type

Circulating DNA

Circulating Tumor Cells

Other

Circulating Biomarker Segment by Application

Early Cancer Screening

Therapy Selection

Treatment Monitoring

Recurrence Monitoring Orthopedics

Circulating Biomarker Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circulating Biomarker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Circulating Biomarker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circulating Biomarker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Circulating Biomarker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Circulating Biomarker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Circulating DNA Table 2. Major Company of Circulating Tumor Cells Table 3. Major Company of Other Table 4. Global Circulating Biomarker Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 6. Global Circulating Biomarker Sales Market Share in Volume by Type (2021-2026) Table 7. Global Circulating Biomarker Sales by Type (2021-2026) & (US$ Million) Table 8. Global Circulating Biomarker Sales Market Share in Value by Type (2021-2026) Table 9. Global Circulating Biomarker Price by Type (2021-2026) & (US$/unit) Table 10. Global Circulating Biomarker Sales by Type (2027-2032) & (k units) Table 11. Global Circulating Biomarker Sales Market Share in Volume by Type (2027-2032) Table 12. Global Circulating Biomarker Sales by Type (2027-2032) & (US$ Million) Table 13. Global Circulating Biomarker Sales Market Share in Value by Type (2027-2032) Table 14. Global Circulating Biomarker Price by Type (2027-2032) & (US$/unit) Table 15. North America Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 16. North America Circulating Biomarker Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 18. Europe Circulating Biomarker Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Circulating Biomarker Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 22. Latin America Circulating Biomarker Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Circulating Biomarker Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Circulating Biomarker Sales by Type (2021-2026) & (US$ Million) Table 25. Circulating Biomarker Industry Trends Table 26. Circulating Biomarker Industry Drivers Table 27. Circulating Biomarker Industry Opportunities and Challenges Table 28. Circulating Biomarker Industry Restraints Table 29. Global Circulating Biomarker Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Circulating Biomarker Revenue Market Share by Company (2021-2026) Table 31. Global Circulating Biomarker Sales by Company (2021-2026) & (k units) Table 32. Global Circulating Biomarker Sales Share by Company (2021-2026) Table 33. Global Circulating Biomarker Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Circulating Biomarker Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Circulating Biomarker Major Company Production Sites and Headquarters Table 36. Global Circulating Biomarker Company, Product Type & Application Table 37. Global Circulating Biomarker Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Circulating Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Circulating Biomarker Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Circulating Biomarker Sales by Region (2021-2026) & (k units) Table 42. Global Circulating Biomarker Sales Market Share in Volume by Region (2021-2026) Table 43. Global Circulating Biomarker Sales by Region (2021-2026) & (US$ Million) Table 44. Global Circulating Biomarker Sales Market Share in Value by Region (2021-2026) Table 45. Global Circulating Biomarker Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Circulating Biomarker Sales by Region (2027-2032) & (k units) Table 47. Global Circulating Biomarker Sales Market Share in Volume by Region (2027-2032) Table 48. Global Circulating Biomarker Sales by Region (2027-2032) & (US$ Million) Table 49. Global Circulating Biomarker Sales Market Share in Value by Region (2027-2032) Table 50. Global Circulating Biomarker Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Circulating Biomarker Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 53. Global Circulating Biomarker Sales Market Share in Volume by Application (2021-2026) Table 54. Global Circulating Biomarker Sales by Application (2021-2026) & (US$ Million) Table 55. Global Circulating Biomarker Sales Market Share in Value by Application (2021-2026) Table 56. Global Circulating Biomarker Price by Application (2021-2026) & (US$/unit) Table 57. Global Circulating Biomarker Sales by Application (2027-2032) & (k units) Table 58. Global Circulating Biomarker Sales Market Share in Volume by Application (2027-2032) Table 59. Global Circulating Biomarker Sales by Application (2027-2032) & (US$ Million) Table 60. Global Circulating Biomarker Sales Market Share in Value by Application (2027-2032) Table 61. Global Circulating Biomarker Price by Application (2027-2032) & (US$/unit) Table 62. North America Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 63. North America Circulating Biomarker Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 65. Europe Circulating Biomarker Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Circulating Biomarker Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 69. Latin America Circulating Biomarker Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Circulating Biomarker Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Circulating Biomarker Sales by Application (2021-2026) & (US$ Million) Table 72. GE Healthcare Company Information Table 73. GE Healthcare Business Overview Table 74. GE Healthcare Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. GE Healthcare Circulating Biomarker Product Portfolio Table 76. GE Healthcare Recent Development Table 77. Fluxion Biosciences Company Information Table 78. Fluxion Biosciences Business Overview Table 79. Fluxion Biosciences Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Fluxion Biosciences Circulating Biomarker Product Portfolio Table 81. Fluxion Biosciences Recent Development Table 82. Epigenomics AG Company Information Table 83. Epigenomics AG Business Overview Table 84. Epigenomics AG Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Epigenomics AG Circulating Biomarker Product Portfolio Table 86. Epigenomics AG Recent Development Table 87. Biocept Company Information Table 88. Biocept Business Overview Table 89. Biocept Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Biocept Circulating Biomarker Product Portfolio Table 91. Biocept Recent Development Table 92. Becton, Dickinson and Company Company Information Table 93. Becton, Dickinson and Company Business Overview Table 94. Becton, Dickinson and Company Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Becton, Dickinson and Company Circulating Biomarker Product Portfolio Table 96. Becton, Dickinson and Company Recent Development Table 97. Agilent Technologies Company Information Table 98. Agilent Technologies Business Overview Table 99. Agilent Technologies Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Agilent Technologies Circulating Biomarker Product Portfolio Table 101. Agilent Technologies Recent Development Table 102. Affymetrix Company Information Table 103. Affymetrix Business Overview Table 104. Affymetrix Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Affymetrix Circulating Biomarker Product Portfolio Table 106. Affymetrix Recent Development Table 107. Abbott Laboratories Company Information Table 108. Abbott Laboratories Business Overview Table 109. Abbott Laboratories Circulating Biomarker Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Abbott Laboratories Circulating Biomarker Product Portfolio Table 111. Abbott Laboratories Recent Development Table 112. North America Circulating Biomarker Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 113. North America Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 114. North America Circulating Biomarker Sales Market Share by Country (2021-2026) Table 115. North America Circulating Biomarker Sales Forecast by Country (2027-2032) & (k units) Table 116. North America Circulating Biomarker Sales Market Share Forecast by Country (2027-2032) Table 117. North America Circulating Biomarker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Circulating Biomarker Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Circulating Biomarker Market Share by Country (2021-2026) Table 120. North America Circulating Biomarker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Circulating Biomarker Market Share Forecast by Country (2027-2032) Table 122. Europe Circulating Biomarker Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. Europe Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 124. Europe Circulating Biomarker Sales Market Share by Country (2021-2026) Table 125. Europe Circulating Biomarker Sales Forecast by Country (2027-2032) & (k units) Table 126. Europe Circulating Biomarker Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Circulating Biomarker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Circulating Biomarker Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Circulating Biomarker Market Share by Country (2021-2026) Table 130. Europe Circulating Biomarker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Circulating Biomarker Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Circulating Biomarker Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 134. Asia-Pacific Circulating Biomarker Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Circulating Biomarker Sales Forecast by Country (2027-2032) & (k units) Table 136. Asia-Pacific Circulating Biomarker Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Circulating Biomarker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Circulating Biomarker Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Circulating Biomarker Market Share by Country (2021-2026) Table 140. Asia-Pacific Circulating Biomarker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Circulating Biomarker Market Share Forecast by Country (2027-2032) Table 142. Latin America Circulating Biomarker Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Latin America Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 144. Latin America Circulating Biomarker Sales Market Share by Country (2021-2026) Table 145. Latin America Circulating Biomarker Sales Forecast by Country (2027-2032) & (k units) Table 146. Latin America Circulating Biomarker Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Circulating Biomarker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Circulating Biomarker Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Circulating Biomarker Market Share by Country (2021-2026) Table 150. Latin America Circulating Biomarker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Circulating Biomarker Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Circulating Biomarker Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Circulating Biomarker Sales by Country (2021-2026) & (k units) Table 154. Middle East and Africa Circulating Biomarker Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Circulating Biomarker Sales Forecast by Country (2027-2032) & (k units) Table 156. Middle East and Africa Circulating Biomarker Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Circulating Biomarker Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Circulating Biomarker Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Circulating Biomarker Market Share by Country (2021-2026) Table 160. Middle East and Africa Circulating Biomarker Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Circulating Biomarker Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Circulating Biomarker Distributors List Table 165. Circulating Biomarker Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Circulating Biomarker Image Figure 2. Global Circulating Biomarker Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Circulating Biomarker Market Size (2021-2032) & (US$ Million) Figure 4. Global Circulating Biomarker Sales (2021-2032) & (k units) Figure 5. Circulating DNA Image Figure 6. Global Circulating DNA Sales YoY Growth (2021-2032) & (k units) Figure 7. Circulating Tumor Cells Image Figure 8. Global Circulating Tumor Cells Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Circulating Biomarker Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Circulating Biomarker Market Share by Type 2025 VS 2032 Figure 13. North America Circulating Biomarker Sales Market Share in Volume by Type in 2025 Figure 14. North America Circulating Biomarker Sales Market Share in Value by Type in 2025 Figure 15. Europe Circulating Biomarker Sales Market Share in Volume by Type in 2025 Figure 16. Europe Circulating Biomarker Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Circulating Biomarker Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Circulating Biomarker Sales Market Share in Value by Type in 2025 Figure 19. Latin America Circulating Biomarker Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Circulating Biomarker Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Circulating Biomarker Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Circulating Biomarker Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Circulating Biomarker Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Early Cancer Screening Image Figure 26. Global Early Cancer Screening Sales YoY Growth (2021-2032) & (k units) Figure 27. Therapy Selection Image Figure 28. Global Therapy Selection Sales YoY Growth (2021-2032) & (k units) Figure 29. Treatment Monitoring Image Figure 30. Global Treatment Monitoring Sales YoY Growth (2021-2032) & (k units) Figure 31. Recurrence Monitoring Orthopedics Image Figure 32. Global Recurrence Monitoring Orthopedics Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Circulating Biomarker Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Circulating Biomarker Market Share by Application 2025 VS 2032 Figure 35. North America Circulating Biomarker Sales Market Share in Volume by Application in 2025 Figure 36. North America Circulating Biomarker Sales Market Share in Value by Application in 2025 Figure 37. Europe Circulating Biomarker Sales Market Share in Volume by Application in 2025 Figure 38. Europe Circulating Biomarker Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Circulating Biomarker Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Circulating Biomarker Sales Market Share in Value by Application in 2025 Figure 41. Latin America Circulating Biomarker Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Circulating Biomarker Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Circulating Biomarker Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Circulating Biomarker Sales Market Share in Value by Application in 2025 Figure 45. North America Circulating Biomarker Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Circulating Biomarker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Circulating Biomarker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Circulating Biomarker Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Circulating Biomarker Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Circulating Biomarker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Circulating Biomarker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Circulating Biomarker Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Circulating Biomarker Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Circulating Biomarker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Circulating Biomarker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Circulating Biomarker Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Circulating Biomarker Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Circulating Biomarker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Circulating Biomarker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Circulating Biomarker Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Circulating Biomarker Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Circulating Biomarker Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Circulating Biomarker Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Circulating Biomarker Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Circulating Biomarker Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Circulating Biomarker Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Circulating DNA
  • Circulating Tumor Cells
  • Other
Applications
  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring Orthopedics
Companies covered
  • GE Healthcare
  • Fluxion Biosciences
  • Epigenomics AG
  • Biocept
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Affymetrix
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Circulating Biomarker Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Circulating Biomarker Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Circulating Biomarker Market by Type
  6. 1.3.1 Circulating DNA
  7. 1.3.2 Circulating Tumor Cells
  8. 1.3.3 Other
  9. 1.4 Global Circulating Biomarker Market Size by Type
  10. 1.4.1 Global Circulating Biomarker Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Circulating Biomarker Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Circulating Biomarker Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Circulating Biomarker Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Circulating Biomarker Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Circulating Biomarker Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Circulating Biomarker Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Circulating Biomarker Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Circulating Biomarker Industry Trends
  2. 2.2 Circulating Biomarker Industry Drivers
  3. 2.3 Circulating Biomarker Industry Opportunities and Challenges
  4. 2.4 Circulating Biomarker Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Circulating Biomarker Revenue (2021-2026)
  2. 3.2 Global Top Players by Circulating Biomarker Sales (2021-2026)
  3. 3.3 Global Top Players by Circulating Biomarker Price (2021-2026)
  4. 3.4 Global Circulating Biomarker Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Circulating Biomarker Major Company Production Sites & Headquarters
  6. 3.6 Global Circulating Biomarker Company, Product Type & Application
  7. 3.7 Global Circulating Biomarker Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Circulating Biomarker Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Circulating Biomarker Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Circulating Biomarker Tier 1, Tier 2, and Tier 3
4 Circulating Biomarker Regional Status and Outlook
  1. 4.1 Global Circulating Biomarker Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Circulating Biomarker Historic Market Size by Region
  3. 4.2.1 Global Circulating Biomarker Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Circulating Biomarker Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Circulating Biomarker Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Circulating Biomarker Forecasted Market Size by Region
  7. 4.3.1 Global Circulating Biomarker Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Circulating Biomarker Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Circulating Biomarker Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Circulating Biomarker by Application
  1. 5.1 Circulating Biomarker Market by Application
  2. 5.1.1 Early Cancer Screening
  3. 5.1.2 Therapy Selection
  4. 5.1.3 Treatment Monitoring
  5. 5.1.4 Recurrence Monitoring Orthopedics
  6. 5.2 Global Circulating Biomarker Market Size by Application
  7. 5.2.1 Global Circulating Biomarker Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Circulating Biomarker Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Circulating Biomarker Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Circulating Biomarker Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Circulating Biomarker Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Circulating Biomarker Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Circulating Biomarker Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Circulating Biomarker Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GE Healthcare
  2. 6.1.1 GE Healthcare Company Information
  3. 6.1.2 GE Healthcare Business Overview
  4. 6.1.3 GE Healthcare Circulating Biomarker Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GE Healthcare Circulating Biomarker Product Portfolio
  6. 6.1.5 GE Healthcare Recent Developments
  7. 6.2 Fluxion Biosciences
  8. 6.2.1 Fluxion Biosciences Company Information
  9. 6.2.2 Fluxion Biosciences Business Overview
  10. 6.2.3 Fluxion Biosciences Circulating Biomarker Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Fluxion Biosciences Circulating Biomarker Product Portfolio
  12. 6.2.5 Fluxion Biosciences Recent Developments
  13. 6.3 Epigenomics AG
  14. 6.3.1 Epigenomics AG Company Information
  15. 6.3.2 Epigenomics AG Business Overview
  16. 6.3.3 Epigenomics AG Circulating Biomarker Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Epigenomics AG Circulating Biomarker Product Portfolio
  18. 6.3.5 Epigenomics AG Recent Developments
  19. 6.4 Biocept
  20. 6.4.1 Biocept Company Information
  21. 6.4.2 Biocept Business Overview
  22. 6.4.3 Biocept Circulating Biomarker Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biocept Circulating Biomarker Product Portfolio
  24. 6.4.5 Biocept Recent Developments
  25. 6.5 Becton, Dickinson and Company
  26. 6.5.1 Becton, Dickinson and Company Company Information
  27. 6.5.2 Becton, Dickinson and Company Business Overview
  28. 6.5.3 Becton, Dickinson and Company Circulating Biomarker Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Becton, Dickinson and Company Circulating Biomarker Product Portfolio
  30. 6.5.5 Becton, Dickinson and Company Recent Developments
  31. 6.6 Agilent Technologies
  32. 6.6.1 Agilent Technologies Company Information
  33. 6.6.2 Agilent Technologies Business Overview
  34. 6.6.3 Agilent Technologies Circulating Biomarker Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Agilent Technologies Circulating Biomarker Product Portfolio
  36. 6.6.5 Agilent Technologies Recent Developments
  37. 6.7 Affymetrix
  38. 6.7.1 Affymetrix Company Information
  39. 6.7.2 Affymetrix Business Overview
  40. 6.7.3 Affymetrix Circulating Biomarker Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Affymetrix Circulating Biomarker Product Portfolio
  42. 6.7.5 Affymetrix Recent Developments
  43. 6.8 Abbott Laboratories
  44. 6.8.1 Abbott Laboratories Company Information
  45. 6.8.2 Abbott Laboratories Business Overview
  46. 6.8.3 Abbott Laboratories Circulating Biomarker Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Abbott Laboratories Circulating Biomarker Product Portfolio
  48. 6.8.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Circulating Biomarker Sales by Country
  2. 7.1.1 North America Circulating Biomarker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Circulating Biomarker Sales by Country (2021-2026)
  4. 7.1.3 North America Circulating Biomarker Sales Forecast by Country (2027-2032)
  5. 7.2 North America Circulating Biomarker Market Size by Country
  6. 7.2.1 North America Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Circulating Biomarker Market Size by Country (2021-2026)
  8. 7.2.3 North America Circulating Biomarker Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Circulating Biomarker Sales by Country
  2. 8.1.1 Europe Circulating Biomarker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Circulating Biomarker Sales by Country (2021-2026)
  4. 8.1.3 Europe Circulating Biomarker Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Circulating Biomarker Market Size by Country
  6. 8.2.1 Europe Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Circulating Biomarker Market Size by Country (2021-2026)
  8. 8.2.3 Europe Circulating Biomarker Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Circulating Biomarker Sales by Country
  2. 9.1.1 Asia-Pacific Circulating Biomarker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Circulating Biomarker Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Circulating Biomarker Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Circulating Biomarker Market Size by Country
  6. 9.2.1 Asia-Pacific Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Circulating Biomarker Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Circulating Biomarker Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Circulating Biomarker Sales by Country
  2. 10.1.1 South America Circulating Biomarker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Circulating Biomarker Sales by Country (2021-2026)
  4. 10.1.3 South America Circulating Biomarker Sales Forecast by Country (2027-2032)
  5. 10.2 South America Circulating Biomarker Market Size by Country
  6. 10.2.1 South America Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Circulating Biomarker Market Size by Country (2021-2026)
  8. 10.2.3 South America Circulating Biomarker Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Circulating Biomarker Sales by Country
  2. 11.1.1 Middle East and Africa Circulating Biomarker Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Circulating Biomarker Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Circulating Biomarker Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Circulating Biomarker Market Size by Country
  6. 11.2.1 Middle East and Africa Circulating Biomarker Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Circulating Biomarker Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Circulating Biomarker Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Circulating Biomarker Value Chain Analysis
  2. 12.1.1 Circulating Biomarker Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Circulating Biomarker Production Mode & Process
  7. 12.2 Circulating Biomarker Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Circulating Biomarker Distributors
  10. 12.2.3 Circulating Biomarker Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst